Iovance Biotherapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 07/05/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 07/05/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 07/08/2025 | Mar 2024Filed 08/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $99 | $71 | $67 | $60 | $49 | $59 | $31 | $0.7 | |
| −$47 | −$79 | −$91 | −$112 | −$116 | −$84 | −$97 | −$113 | |
| −$0.11 | −$0.19 | −$0.25 | −$0.33 | −$0.36 | −$0.28 | −$0.34 | −$0.42 |
Trend